Authors
    • Obstetrics and Gynecology
    • Professor of Obstetrics and Gynecology, Professor of Cell Biology, Director of Perinatal Research Division, Chief of Obstetrics and Maternal Fetal Medicine, Jennie Sealy Smith Distinguished Chair in Obstetrics and Gynecology at University of Texas Medical Branch- Galveston TX
    Dr. George Saade is currently Professor of Obstetrics and Gynecology, Professor of Cell Biology, Director of the Perinatal Research Division, Chief of Obstetrics and Maternal-Fetal Medicine and the Jennie Sealy Smith Distinguished Chair in Obstetrics and Gynecology at the University of Texas Medical Branch in Galveston. Dr. Saade is an elected member of the Tau Beta Pi Engineering Honor Society, Alpha Omega Alpha, the Society for Gynecologic Investigation, and the American Gynecologic and Obstetric Society. He has served on the Executive Committee of the Society for Maternal Fetal Medicine in various functions, most recently as its president. He is also the chair of the Health Policy Committee of the Society for Maternal Fetal Medicine. He has been a member of the editorial board of several journals, most recently Obstetrics and Gynecology, and is the editor in chief of the American Journal of Perinatology. Dr. Saade has served on and chaired a number of national and international advisory committees, scientific review panels and study sections, including NIH, CDC, March of Dimes, National Academies of Sciences, Wellbeing/Royal College of Obstetricians and Gynaecologists, and the Health Research Council of New Zealand. He is the chair of the Texas Collaborative for Healthy Mothers and Children. He is a member of the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Advisory Council. He is also actively involved in training scientists in the field, both as chair or member of PhD student committees and as a mentor to postdoctoral fellows. Dr. Saade is certified by the American Board of Obstetrics and Gynecology and Maternal-Fetal Medicine, and is an examiner for both. His areas of interest include smooth muscle physiology as applied to vascular and myometrial function during pregnancy, as well as adverse intrauterine environment and fetal programming of adult diseases. Dr. Saade is currently the principal investigator on 2 NIH-funded clinical research networks, the Stillbirth Collaborative Research Network and the Maternal Fetal Medicine Units Network. He is also the co-investigator on 3 other NIH-funded grants. His clinical area of expertise revolves around stillbirth and preterm birth. He has authored more than 200 peer-reviewed publications, and is the editor of Critical Care Obstetrics textbook and the Maternal Medicine textbook. He is also actively involved in clinical practice in Maternal Fetal Medicine, and has been voted as Best Doctor and selected to Super Doctors several years in a row.
    • Maternal and Fetal Medicine
    • Ellen Jacobson Levine and Eugene Jacobson Associate Professor of Women's Health in Obstetrics and Gynecology, Maternal-Fetal Medicine, Director, Maternal-Fetal Medicine Fellowship Program, Alternate PI, Maternal-Fetal Medicine Units Network at Columbia University Medical Center
    Dr. Gyamfi is board certified in both Obstetrics/Gynecology and Maternal-Fetal Medicine. As a Maternal-Fetal Medicine (MFM) specialist, she focuses on obstetric complications with a primary focus on preterm birth prevention. However, she also focuses on gestational diabetes, preeclampsia and thrombophilias in pregnancy. Her clinical practice includes caring for high risk patients, performing detailed ultrasounds and procedures for prenatal diagnosis. She is the Director of the Maternal-Fetal Medicine Fellowship Training Program, where she oversees the training and development of future MFM physicians. She is also the Medical Director of the Perinatal Clinics at Columbia, where residents and fellows work closely with MFM faculty to learn to care for women with high risk pregnancies. Dr. Gyamfi is also a proficient, NIH-funded researcher working on multiple clinical trials. As lead PI, she recently completed the multi-center, randomized ALPS trial designed to improve neonatal outcomes in infants of women at risk for late preterm birth. This paper is now published in the New England Journal of Medicine. A long-term follow-up to this study is planned. She also conducts research in the areas of preterm birth, antenatal corticosteroids, preeclampsia, CMV and, genetic determinants of neonatal respiratory morbidity related to preterm birth. Her Masters of Science degree in Biostatistics allows her the opportunity to run analyses on existing or developed datasets and provides a unique insight into clinical obstetric research. She is an integral part of Columbia’s team of investigators in the Maternal-Fetal Medicine Units Network at the National Institutes of Health and has numerous publications in the area of prematurity, antenatal corticosteroids, thyroid disease and, Jehovah’s Witness care. Aside from her clinical and research endeavors, Dr. Gyamfi is a member of the Board of the Society for Maternal-Fetal Medicine (SMFM), where she was previously the Associate Member Representative. She serves as a member of the SMFM Publications Committee, a national group of highly-regarded MFM specialists who write guidelines on clinical practice for MFM-subspecialists; and is a founding member of the SMFM Research Committee. She has been selected as a faculty member for the annual NICHD conference directed at stimulating research interests and collaboration between MFM and Neonatal fellows-in-training on various occasions, and she has served as the Chair of the AAP/Abbott sponsored Santa Fe conference for Neonatal and Perinatal Fellows. As MFM Fellowship Director at Columbia University, she oversees the training of 9 fellows, making this one of the largest training programs in the country. She has been invited to speak about her research locally, nationally, and internationally. Dr. Gyamfi’s special interests include epidemiology and biostatistics as well as maternal and obstetric complications of pregnancy including prevention of preterm birth, diabetes in pregnancy, antenatal corticosteroids, chronic hypertension, thrombophilias, anemia and pregnancy in special populations such as Jehovah’s Witnesses.
    • Maternal and Fetal Medicine
    Director of the Prenatal Genetic Screening Program, UCSF
    Director of the Prenatal Genetic Screening Program, UCSF
    Mary Norton is a professor in the Maternal Fetal Medicine Division of the Department of Obstetrics, Gynecology and Reproductive Sciences. She earned her BA in zoology and Russian at the University of Washington, and also earned her Medical Degree at UW. She completed her Ob/Gyn residency at Tufts University in Boston and then went on to complete her fellowship in Maternal Fetal Medicine and Clinical Genetics at UCSF. She is board-certified in Obstetrics and Gynecology and Maternal Fetal Medicine, as well as in Clinical Genetics. She is currently Vice Chair of Clinical and Translational Genetics and Director of the Prenatal Genetic Screening Program at the University of California, San Francisco. She is also presently the interim co-division chief of the medical genetics division in the Department of Pediatrics. She is interested in public policy and public health surrounding prenatal genetic testing programs, and is a member of the Perinatal Advisory Committee for the California State Genetic Disease Screening Program. Her research interests include genetic testing and its application to prenatal screening and diagnosis. She focuses on the unique aspects of translating new technologies into improved care for pregnant women and their fetuses. She is currently involved in projects that include mechanisms and disorders associated with nonimmune hydrops fetalis and potential for in utero therapy, and application of whole exome and genome sequencing in the prenatal context. Her other research and clinical interests involve prenatal genetic screening and diagnostic testing, obstetrical ultrasound, fetal therapy, and patient preferences and decision-making.